Develops, manufactures and markets medical products based on genetic probe technology. The Company's development programs focus on infectious disease diagnostic products. By identifying the genetic material of a disease-causing microorganism (rather than relying on cultures), the Company's products can provide test results within hours. The Company is also using its technology in the research and development of cancer diagnostic products and therapeutic products.